Alvotech (ALVO) Net Cash Flow (2021 - 2026)
Alvotech's (ALVO) quarterly Net Cash Flow came in at -$72.4 million in Q1 2026, down 718.26% YoY from $11.7 million in Q1 2025, and down 117.99% on a QoQ basis from $402.4 million in Q4 2025.
Alvotech (ALVO) Net Cash Flow (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Net Cash Flow data on file, last reported at -$72.4 million in Q1 2026.
- Quarterly Net Cash Flow fell 718.26% year-over-year to -$72.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.9 million (up 125.54% YoY) and the FY2025 annual result came in at $116.4 million, up 179.89% from the prior year.
- Net Cash Flow eased to -$72.4 million in Q1 2026, from $402.4 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $402.4 million in Q4 2025 to a low of -$382.6 million in Q3 2025.
- A 5-year average of -$64.2 million and a median of -$53.7 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2025 — Net Cash Flow soared 874.4% — and 2026, when it slumped 718.26%.
- Tracing ALVO's Net Cash Flow over 5 years: stood at -$375.9 million in 2022, then increased by 10.12% to -$337.9 million in 2023, then soared by 112.22% to $41.3 million in 2024, then soared by 874.4% to $402.4 million in 2025, then tumbled by 117.99% to -$72.4 million in 2026.
- The last three Net Cash Flow figures came in at -$72.4 million (Q1 2026), $402.4 million (Q4 2025), and -$382.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alvotech | 1.23 Bn | 1.23 Bn | 5.09 Mn | -107.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -72.41 Mn |
| Mar 31, 2026 | -72.41 Mn |
| Dec 31, 2025 | 402.45 Mn |
| Dec 31, 2025 | 402.45 Mn |
| Sep 30, 2025 | -382.63 Mn |
| Sep 30, 2025 | -382.63 Mn |
| Jun 30, 2025 | 105.45 Mn |
| Jun 30, 2025 | 105.45 Mn |
| Mar 31, 2025 | -8.85 Mn |
| Mar 31, 2025 | -8.85 Mn |
| Dec 31, 2024 | 41.30 Mn |
| Dec 31, 2024 | 41.30 Mn |
| Sep 30, 2024 | -185.78 Mn |
| Sep 30, 2024 | -185.78 Mn |
| Jun 30, 2024 | -53.68 Mn |
| Jun 30, 2024 | -53.68 Mn |
| Mar 31, 2024 | 54.30 Mn |
| Mar 31, 2024 | 54.30 Mn |
| Dec 31, 2023 | -337.86 Mn |
| Dec 31, 2023 | -337.86 Mn |